Showing 341 - 360 results of 1,859 for search '"Immunotherapy"', query time: 0.06s Refine Results
  1. 341
  2. 342
  3. 343

    Long-term sublingual bacterial immunotherapy prevents ear, nose and throat infections: A real-life study by Paula F Aarestrup, Matheus F Aarestrup, Beatriz JV Aarestrup, Edir P Cheloni, Fernando M Aarestrup

    Published 2025-01-01
    “…Methods: Patients received sublingual bacterial immunotherapy for 12 months and were followed for 24 months. …”
    Get full text
    Article
  4. 344

    Shrimp allergen extract immunotherapy induces prolonged immune tolerance in a gastro-food allergy mouse model. by Honey Dzikri Marhaeny, Lutfiatur Rohmah, Yusuf Alif Pratama, Salsabilla Madudari Kasatu, Andang Miatmoko, Rafi Addimaysqi, Geert van den Bogaart, Franz Y Ho, Muhammad Taher, Junaidi Khotib

    Published 2024-01-01
    “…This study aimed to determine the effectiveness of SAE in inducing immunological tolerance in a gastro-food allergy mouse model. For the immunotherapy evaluation, mice (n = 24) were intraperitoneally (i.p.) sensitized with 1 mg alum and 100 μg SAE in PBS on days 0, 7, and 14 and randomly divided into four groups of six: a negative control (NC) and high- to low-dose immunotherapy (HI, MI, and LI). …”
    Get full text
    Article
  5. 345

    Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy by Tao Xu, Kehan Liu, Shuqi Mi, Yao Yao, Mengyao Zhang, Shujuan Xue, Feng Zhi, Sally-Ann Cryan, Dawei Ding

    Published 2025-04-01
    “…Low immunogenicity and immunosuppressive tumor microenvironment (TME) are two pivotal factors restricting tumor immunotherapy. Photodynamic therapy (PDT) directly destroys cancer cells by producing reactive oxygen species (ROS), and enhances the immunogenicity of ''cold'' tumors by inducing immunogenic cell death (ICD), thereby promoting T cell development against tumors. …”
    Get full text
    Article
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350

    Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes by John Ammori, Khaled Hamzeh, Hallie Graor, Julian Kim

    Published 2015-01-01
    “…The purpose of this study was to determine the cellular effectors of both the adoptively transferred cells and the tumor-bearing host that participate in the antitumor response to adoptive immunotherapy using culture-activated tumor-draining lymph nodes (TDLNs). …”
    Get full text
    Article
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355

    Reaction-Diffusion on a Spatial Mathematical Model of Cancer Immunotherapy with Effector Cells and IL-2 Compounds’ Interactions by Sulasri Suddin, Fajar Adi-Kusumo, Lina Aryati, Gunardi

    Published 2021-01-01
    “…Immunotherapy is one of the future treatments applicable in most cases of cancer including malignant cancer. …”
    Get full text
    Article
  16. 356
  17. 357
  18. 358
  19. 359
  20. 360